Behavioral phenotyping in zebrafish assesses CNS drug effects through high-throughput screening and predictive preclinical insights

How zebrafish models are advancing microbiome studies, including germ-free models and gut development insights for translational research.

How zebrafish models support retinal repair studies and preclinical research into stem-cell-based eye therapies.

How zebrafish neurological models bridge in vitro and mammalian systems to enable high-throughput, functional disease modeling for early-stage drug discovery.

Why zebrafish male vs female differences impact in drug discovery. Improve preclinical efficacy and safety with sex-aware zebrafish models.

Zebrafish efficacy assays unlock therapeutic potential in drug discovery. Explore applications in cancer research, neurology, and regenerative medicine.

Zebrafish neurotoxicity screening helps predict drug safety, identifying neurotoxicity symptoms, risk factors, and effects with precise in vivo models.

How zebrafish enhance cardiotoxicity screening, improve early detection of cardiac risk, and support safer drug development in preclinical studies.

Developmental neurotoxicity insights using zebrafish behavioral assays: discover how this in vivo model advances preclinical drug discovery decisions.

Zebrafish cancer models enable in vivo drug screening and tumor tracking, helping develop targeted anticancer therapies in oncology drug development.

Discover how zebrafish models of human disease are revolutionizing research in neurology, oncology, infections, and rare disorders with real-world breakthroughs.

Discover how zebrafish are advancing modeling human diseases in neurology, cardiology, oncology, and ophthalmology.

Explore zebrafish disease models built with CRISPR, Tol2, and morpholinos for precise genetic research.

Discover why zebrafish are becoming key human disease models for studying genetics, disease mechanisms, and drug discovery with speed and precision.

Discover the strengths and limitations of zebrafish, mice, and other model organisms, comparing human gene homology, brood size and life cycle.

Discover how zebrafish preclinical research accelerates drug discovery. Explore 3 key use cases for efficacy, toxicity, and disease modeling.

Learn about zebrafish development, from embryo to larvae. Discover the zebrafish developmental stages and why they’re ideal for biomedical research.

Exploring the Benefits of Zebrafish Model in Modern Research

Leveraging Zebrafish for Reduction, Refinement, and Replacement in Preclinical Studies

Identifying Successfully Injected Embryos With Fluorescence

How To Do A Microinjection of Zebrafish Embryos?

Proven Techniques for Successful Zebrafish Reproduction and Embryo Collection

Understanding Shared Genes and Their Impact on Human Medicine

What Does Zebrafish Eat? Balancing Nutrition and Convenience with Live and Dry Food

Essential Zebrafish Husbandry Practices for Effective Tank Cleaning and Disinfection

Best Practices for Zebrafish Husbandry: Monitoring Health and Maintaining Rack Systems

Best Practices for Long-Term Zebrafish Care and Husbandry

A Step-by-Step Guide to Establishing a Thriving Zebrafish Colony

Essential Water Quality Tips for Healthy and Thriving Zebrafish

Temperature, pH, Conductivity and Density Guidelines for Zebrafish Husbandry

Understanding Zebrafish Biology and Behavior in Research

From Ornamental Fish to a Cornerstone of Scientific Discovery

Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.

Zebrafish contribution to drug development reaching clinical stages

Zebrafish for regulatory purposes in ecotoxicology and safety pharmacology

New trends and updated availability for zebrafish studies in EU and US

Are zebrafish suitable for human drug discovery?

The regulatory status of zebrafish as an alternative preclinical model.

In ZeClinics we bet on emerging technologies to scale our solutions.

ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.

We knew the model was brilliant for academic research. Would it be as good for modeling human disease and discovering new drugs in an industrial setting?